pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Jun 5·1 min read
save

NIH senior adviser promotes MAHA strategy at ADA conference amid skeptical audience

Jun 5, 2026·read at STAT ↗Neutral

At the American Diabetes Association meeting in New Orleans, Richard Woychik, a senior adviser to NIH Director Jay Bhattacharya, opened his remarks by endorsing the Make America Healthy Again (MAHA) initiative.

He explained that the MAHA strategy aims to coordinate NIH-wide innovation to better prevent and reduce the burden of diabetes, positioning the disease as a key example of why an integrated approach to chronic conditions is needed.

The audience responded with a mix of cheers and skepticism, especially when Woychik addressed concerns about recent federal funding cuts to biomedical research and was asked to justify the policy’s priorities.

The discussion highlighted ongoing tension between NIH leadership’s policy agenda and the research community’s expectations for stable funding and clear strategic direction.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Senior NIH official pushes MAHA strategy to skeptical ADA audience”

read at STAT ↗
1,313 words · retrieved Jun 5
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
LEADING2National Institutes of Health2
drugs
STERILE WATER2
topics
Type 2 Diabetes11Vaccines6Cardiology5Vaccine3Endocrinology & Metabolism2ImmunologyPsychiatry & CNS

related stories

  • 3d agoA winner, a loser, and a mid-stage signal from a major cardiology research conferenceSTAT
  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • Aug 26Newer shingles vaccine linked to lower heart disease risk, ‘natural experiment’ showsSTAT
  • Dec 22Fierce Biotech Fundraising Tracker '26: Superluminal snags $60M; AusperBio adds $120MFierce Biotech
  • 19h agoNovartis may cut around 130 in Switzerland while relocating biologics productionBioSpace